Recently Viewed
Clear AllQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Bidding Date
08-Aug-2025 to
12-Aug-2025
Issue Size
₹69.47 Cr
Price Band
₹135 to ₹142
Allotment date
13-Aug-2025
Listing date
18-Aug-2025
Lot size
1000
No. of shares
48,92,000
Fresh issue/OFS
₹55.66 Cr/₹13.8 Cr
Star Imaging and Path Lab Limited, with roots tracing back to 1978, is a comprehensive diagnostic service provider offering advanced pathology, radiology, cardiology, and neurology solutions. Operating NABL-accredited facilities, the company serves Delhi, Uttar Pradesh, and Nasik through B2C, B2B, and B2G models. Its services span a wide spectrum, from routine and specialized pathology tests to high-end imaging like MRI, CT scans, mammography, ultrasound, and bone density analysis. With a dedicated tele-radiology hub and state-of-the-art technology, the company delivers precise, timely, and accessible diagnostics, supporting early detection, accurate diagnosis, and effective treatment planning for diverse healthcare needs.
Category
Status
QIBs
12.9x
NIIs
3x
Retail
2.3x
Others
0.3x
Total
5x
The issue size of Star Imaging and Path Lab is ₹69.47 Cr.
Star Imaging and Path Lab falls into Healthcare & Services industry.
The Star Imaging and Path Lab IPO will be listed on NSE.
The open and close dates for the Star Imaging and Path Lab are 08-Aug-2025 & 12-Aug-2025.
The price band for the Star Imaging and Path Lab ipo is ₹135 to ₹142
The listing date of Star Imaging and Path Lab IPO is 18-Aug-2025.
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
Star Imaging and Path Lab total subscription ratio is 5X.
Key financial of the Star Imaging and Path Lab are:
| Star Imaging and Path Lab | FY-25 | FY-24 | FY-23 | FY-22 |
|---|---|---|---|---|
| Revenue (₹ Cr) | 83.5 | 78.78 | 58.53 | 69.09 |
| EBIT (₹ Cr) | 23.69 | 17.39 | 2.7 | 11.15 |
| Proft after Tax (₹ Cr) | 15.96 | 12.45 | 0.58 | 6.29 |
| Debt (₹ Cr) | 32.73 | 30.64 | 26.56 | 29.56 |
| Net Worth (₹ Cr) | 47.23 | 31.4 | 18.95 | 18.36 |
| RoE (%) | 33.78 | 39.66 | 3.08 | 34.26 |